probiotics and postoperative weight loss of sleeve surgeries
Phase 3
- Conditions
- Morbid Obesity.Overweight and obesity
- Registration Number
- IRCT20210817052218N2
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
patients aged between 18 and 65 years
morbidly-obese patients candidates for bariatric surgery , BMI above 40 kg/m2
Exclusion Criteria
Chronic damage to the digestive system, liver and kidney
Insulin use within 4 weeks before the start of the study and during the study
Patients with micronutrient deficiency of vitamin D, folic acid and iron storage
Pregnant patients
Consuming foods enriched with probiotics within 4 weeks before the start of the study and during the study
Corticistreoid consumption within 4 weeks before the start of the study and during the study
Taking immunosuppressive drugs within 4 weeks before the start of the study and during the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method BMI (body mass index). Timepoint: Before, three and six months after the intervention. Method of measurement: scale.;Fat mass. Timepoint: Before, three and six months after the intervention. Method of measurement: According to the measurement of anthropometric index with the inbody 370 bioimpedance analyzer (Biospace America, Inc.).;Muscle mass. Timepoint: Before, three and six months after the intervention. Method of measurement: According to the measurement of anthropometric index with the inbody 370 bioimpedance analyzer (Biospace America, Inc.).;Excess body weight loss. Timepoint: Before, three and six months after the intervention. Method of measurement: Calculation based on the difference between the patient's weight and the difference between the preoperative weight and the ideal weight.
- Secondary Outcome Measures
Name Time Method